Fiesta Restaurant Group Inc. (FRGI) Jumps 5.24% on January 13

Equities Staff  |

Fiesta Restaurant Group Inc. (FRGI) was among the biggest gainers on the Russell 2000 for Wednesday January 13 as the stock popped 5.24% to $35.34, representing a gain of $1.76 per share. Some 975,918 shares traded hands on 6,399 trades, compared with an average daily volume of 357,225 shares out of a total float of 26.83 million. The stock opened at $33.77 and traded with an intraday range of $37.09 to $33.77.

After today's gains, Fiesta Restaurant Group Inc. reached a market cap of $948.16 million. Fiesta Restaurant Group Inc. has had a trading range between $69.00 and $31.70 over the last year, and it had a 50-day SMA of $35.06 and a 200-day SMA of $46.87.

The stock has a P/E Ratio of 23.3.

Fiesta Restaurant Group Inc through its wholly-owned subsidiaries owns, operates and franchises two fast-casual restaurant brands, Pollo Tropical and Taco Cabana. It offers freshly prepared Caribbean inspired food and authentic Mexican food.

Fiesta Restaurant Group Inc. is based out of Addison, TX and has some 10,600 employees. Its CEO is Timothy P. Taft.

For a complete fundamental analysis analysis of Fiesta Restaurant Group Inc., check out’s Stock Valuation Analysis report for FRGI. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Crypto World in Review: Taking in the Good with the Bad

A lot happened in the cryptocurrency industry this week.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.